Sun’s Key Halol Plant Flunks FDA Inspection Again

The US FDA has flagged more issues at Indian firm Sun Pharma’s largest manufacturing plant in Halol but analysts are hoping the infractions are minor and that the Indian facility will get the regulatory green light soon, ending a blacklist on the factory supplying new products to the US.

production line

More from India

More from Focus On Asia